AKT1 and cancer: Furthermore, inhibiting the PI3K/AKT pathway with wortmannin and LY294002 sensitised PDAC cells to GEM [52] and inhibition of PKB/AKT by wortmannin was shown to promote the anti‐cancer activities of GEM in PDAC mouse models [53].